A share price of HCA Healthcare Inc [HCA] is currently trading at $459.68, down -1.53%. An important factor to consider is whether the stock is rising or falling in short-term value. The HCA shares have gain 2.83% over the last week, with a monthly amount glided 7.73%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research downgraded its rating to Peer Perform on July 28, 2025. On July 16, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $394 on the stock. Wells Fargo upgraded its rating to an Equal Weight but stick to its price target of $385 on May 29, 2025. Robert W. Baird downgraded its rating to a Neutral but $336 remained the price target by the analyst firm on April 15, 2025. In a note dated November 25, 2024, Wells Fargo downgraded an Underweight rating on this stock and revised its target price from $400 to $320.
HCA Healthcare Inc experienced fluctuations in its stock price throughout the past year between $289.98 and $478.19. Currently, Wall Street analysts expect the stock to reach $483.33 within the next 12 months. HCA Healthcare Inc [NYSE: HCA] shares were valued at $459.68 at the most recent close of the market. An investor can expect a potential return of 5.14% based on the average HCA price forecast.
Analyzing the HCA fundamentals
Trailing Twelve Months sales for HCA Healthcare Inc [NYSE:HCA] were 74.37B which represents 9.57% growth. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is -1.62 and Total Capital is 0.28. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-8.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 455.04 points at the first support level, and at 450.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 465.21, and for the 2nd resistance point, it is at 470.75.
Ratios To Look Out For
To put it in perspective, the Current Ratio for HCA Healthcare Inc [NYSE:HCA] is 0.85. On the other hand, the Quick Ratio is 0.76, and the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 1.41 and price to earnings (TTM) ratio is 17.76.
Transactions by insiders
Recent insider trading involved Cuffe Michael S., Officer, that happened on Sep 08 ’25 when 3836.0 shares were purchased. EVP and Chief Clinical Officer, Cuffe Michael S. completed a deal on Sep 08 ’25 to sell 3836.0 shares. Meanwhile, EVP and COO Foster Jon M sold 15698.0 shares on May 13 ’25.
